| Not Yet Recruiting | ACT for Veterans With IBD and Mental Health Challenges NCT07397195 | VA Office of Research and Development | N/A |
| Not Yet Recruiting | Dose Ranging Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Rectal Foam in Pediatr NCT05976802 | Bausch Health Americas, Inc. | Phase 4 |
| Not Yet Recruiting | Digital Mind Body Intervention Among Black and Hispanic Patients Living With Inflammatory Bowel Disease NCT06510296 | Montefiore Medical Center | N/A |
| Not Yet Recruiting | Heart Rate Variability (HRV) Biofeedback to Treat Ulcerative Colitis NCT05892159 | Icahn School of Medicine at Mount Sinai | N/A |
| Not Yet Recruiting | Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refra NCT07513181 | Athos Therapeutics Inc | Phase 2 |
| Not Yet Recruiting | Aquamin® for Prevention of Ulcerative Colitis J-Pouch-associate Intestinal Inflammation NCT07501078 | Muhammad N Aslam, MD | Phase 2 |
| Not Yet Recruiting | Microbiome-targeted Diet Therapy in Ulcerative Colitis NCT07520461 | University of Minnesota | N/A |
| Not Yet Recruiting | Describing Treatment Patterns and Creating an Updated Treatment Flow in an Ulcerative Colitis Population NCT07177209 | Pfizer | — |
| Not Yet Recruiting | Development of the SC-IBD Self-Care Measurement Scale NCT07494227 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Not Yet Recruiting | Naturopathic Approaches to Ulcerative Colitis NCT07521904 | National University of Natural Medicine | — |
| Not Yet Recruiting | A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerati NCT07463183 | Merck Sharp & Dohme LLC | Phase 2 |
| Not Yet Recruiting | Piloting an Insomnia Treatment in Patients With Ulcerative Colitis NCT07428629 | Dartmouth-Hitchcock Medical Center | N/A |
| Not Yet Recruiting | Fecal Microbiota Transplantation in an Expanded Ulcerative Colitis Population NCT07401680 | University of Alberta | Phase 1 |
| Not Yet Recruiting | Lipopolysaccharide Adsorption (Efferon LPS) in Patients With Ulcerative Colitis and Crohn Disease NCT07383597 | Efferon JSC | N/A |
| Not Yet Recruiting | Developing a Self-Management Intervention to Improve Health Outcomes for Patients With Inflammatory Bowel Dise NCT07456566 | University of Michigan | N/A |
| Not Yet Recruiting | Outcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications NCT07240649 | Jay C. Buckey Jr. | Phase 4 |
| Recruiting | A Retrospective Study to Evaluate Treat-to-Target and Disease Modification in Adult Participants With Crohn's NCT07421258 | AbbVie | — |
| Not Yet Recruiting | Thermal Measurements of the Gut With a Colonoscope Compatible Thermal Probe NCT07352995 | Massachusetts General Hospital | N/A |
| Not Yet Recruiting | Efficacy of Acupuncture-Mesalazine Combination Therapy in Ulcerative Colitis. NCT07389824 | Qin Yu | N/A |
| Recruiting | Desloratadine in Patients With Ulcerative Colitis NCT07333716 | Tanta University | Phase 2 |
| Recruiting | A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Sev NCT07185009 | Sanofi | Phase 3 |
| Completed | A Study on Infections in Adults With Ulcerative Colitis/Crohn's Disease NCT07250815 | Takeda | — |
| Recruiting | Study Evaluating ISM5411 Administered Orally to Subjects With Active Ulcerative Colitis (BETHESDA) NCT07265570 | InSilico Medicine Hong Kong Limited | Phase 2 |
| Not Yet Recruiting | A Study of Ozanimod in Pregnant Women With Ulcerative Colitis and Their Offspring NCT05953402 | Bristol-Myers Squibb | — |
| Not Yet Recruiting | Role of Bile Acids and Microbiota in Clostridioides Difficile Infection in Ulcerative Colitis NCT06228352 | Assistance Publique - Hôpitaux de Paris | — |
| Recruiting | LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative NCT07186101 | Eli Lilly and Company | Phase 2 |
| Recruiting | Patient Preference for Subcutaneous vs. Intravenous Immune Therapy NCT07223424 | Diwakar Davar | Phase 2 |
| Recruiting | A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's D NCT06405087 | Takeda | Phase 3 |
| Recruiting | Study to Assess Change in Disease Activity of Risankizumab Treatment in Japanese Participants With Moderate to NCT07136116 | AbbVie | — |
| Recruiting | An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Seve NCT07184996 | Sanofi | Phase 3 |
| Recruiting | Study of Novel Therapeutics for Acute Remedy of Colitis NCT06420492 | Brigham and Women's Hospital | Phase 2 |
| Recruiting | A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderate NCT06979336 | Genentech, Inc. | Phase 2 |
| Recruiting | A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis NCT06865417 | Alfasigma S.p.A. | Phase 3 |
| Recruiting | Evaluation of a Remote Monitoring Application in the Follow-up of Patients With Active Inflammatory Bowel Dise NCT06742385 | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | N/A |
| Completed | Composite Ratios Boost CRP's Power in Monitoring Ulcerative Colitis. NCT07261579 | Benha University | — |
| Not Yet Recruiting | Cohort of Patients With Ulcerative Colitis or Polyps Followed in CHU de Bordeaux Associated With a Biocollecti NCT07082231 | University Hospital, Bordeaux | N/A |
| Not Yet Recruiting | MOdel-Informed Precision Dosing of Ustekinumab and VEdolizumab in Inflammatory Bowel Disease NCT06788340 | Odense University Hospital | Phase 4 |
| Withdrawn | Mini-MARVEL - Mitochondrial Antioxidant Therapy in Ulcerative Colitis NCT05539625 | University of Edinburgh | Phase 2 |
| Recruiting | Long-term Safety and Efficacy of Sacral Nerve Stimulation in Patients With Ulcerative Colitis NCT07114159 | Xijing Hospital | N/A |
| Recruiting | A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis NCT07071519 | AbbVie | Phase 3 |
| Recruiting | Rupatadine in Patients With Ulcerative Colitis NCT07064707 | Alexandria University | Phase 2 |
| Recruiting | A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis NCT06975722 | Sanofi | Phase 2 |
| Recruiting | Ten Versus Fifteen Centimeter Pouch in IPAA Surgery NCT06538402 | Odense University Hospital | N/A |
| Recruiting | Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Act NCT06937086 | Eli Lilly and Company | Phase 3 |
| Recruiting | A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Coli NCT06880744 | AbbVie | Phase 3 |
| Recruiting | A Study of Filgotinib 200 mg in Korean Participants With Moderately to Severely Active Ulcerative Colitis Unde NCT06964113 | Eisai Korea Inc. | Phase 4 |
| Recruiting | Personalized Anti-Inflammatory Fibres in Ulcerative Colitis NCT06515210 | University of Alberta | N/A |
| Not Yet Recruiting | A Comparative Evaluation of Different Histopathological Indices of Mucosal Healing in Ulcerative Colitis NCT06918093 | Assiut University | — |
| Not Yet Recruiting | Efficacy of Subcutaneous Infliximab in Acute Severe Ulcerative Colitis: a Multicenter Retrospective Study NCT06998797 | Central Hospital, Nancy, France | — |
| Recruiting | Nitazoxanide in Patients With Ulcerative Colitis NCT06993974 | Alexandria University | Phase 2 |
| Recruiting | A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD) NCT06764615 | Takeda | Phase 2 |
| Recruiting | A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis NCT07012395 | Spyre Therapeutics, Inc. | Phase 2 |
| Recruiting | Treatment of UC With Novel Therapeutics NCT06420375 | Brigham and Women's Hospital | Phase 2 |
| Recruiting | Mirikizumab Real World Protocol NCT06696014 | University of North Carolina, Chapel Hill | — |
| Recruiting | Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowe NCT06750731 | Mercy Medical Center | — |
| Not Yet Recruiting | Spondylo-arthritis Screening Tool Among Patient Suffering From Inflammatory Bowel Disease NCT06998316 | University Hospital, Grenoble | — |
| Recruiting | An Observational Study to Evaluate Effectiveness and Safety of Upadacitinib in Chinese Adult Participants With NCT06838845 | AbbVie | — |
| Recruiting | Evaluation of Sleep Changes in Inflammatory Bowel Diseases (IBD) Patients. NCT05835973 | Hospices Civils de Lyon | N/A |
| Recruiting | A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting NCT06581328 | Takeda | Phase 4 |
| Recruiting | A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Ul NCT06906445 | All India Institute of Medical Sciences | N/A |
| Recruiting | Tailored Anti-Inflammatory (A-I) Diet for Americans With Ulcerative Colitis (UC) NCT06784323 | University of Miami | N/A |
| Not Yet Recruiting | Combined Application of EEN in the Induction of Remission in PUC NCT04999241 | Children's Hospital of Fudan University | Phase 4 |
| Recruiting | Study to Assess Change in Disease Activity of Risankizumab Treatment in Adult Participants With Moderate to Se NCT06764706 | AbbVie | — |
| Recruiting | Spatially and Temporally Resolving Predictive Biomarkers of Postoperative Recurrence and Complications in Chro NCT06516341 | IRCCS Ospedale San Raffaele | — |
| Not Yet Recruiting | Whey Protein Milk-Derived Exosomes NCT06755021 | Exosomm Ltd. | N/A |
| Completed | Effect of Rutin on Inflammation Pathways in Ulcerative Colitis Patients NCT07370220 | Benha University | Phase 2 |
| Recruiting | Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately to Severely Active Ulcerative Coli NCT06453317 | Medical University of Lodz | Phase 2 |
| Completed | Determine PK Profiles of Ozanimod and Its' Major Metabolites in Healthy Subjects NCT06528665 | Corium Innovations, Inc. | — |
| Enrolling By Invitation | Estimation of Cardiovascular Risk in Patients With Crohn's Disease and Ulcerative Colitis (PROVACI) NCT07095634 | IRCCS Policlinico S. Donato | — |
| Recruiting | Beneficial Effect of Silymarin in Ulcerative Colitis NCT06213857 | Tanta University | Phase 2 |
| Recruiting | BOOM-IBD2 Pivotal Clinical Trial NCT06571669 | Boomerang Medical | N/A |
| Recruiting | A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease NCT06100289 | Takeda | Phase 3 |
| Recruiting | A Study of AC-101 Tablets in Participants With Moderate to Severe Active Ulcerative Colitis NCT07083193 | Accro Bioscience (Suzhou) Limited | Phase 1 / Phase 2 |
| Enrolling By Invitation | Utility of Random Biopsies in Patients With Inflammatory Bowel Disease NCT06560021 | Abramson Cancer Center at Penn Medicine | N/A |
| Unknown | Clinical Outcome of Treatment of Ulcerative Colitis in Adult NCT06143163 | Assiut University | — |
| Active Not Recruiting | A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis NCT06636656 | Boehringer Ingelheim | Phase 2 |
| Recruiting | Development of Novel Imaging and Molecular Biomarkers of Fibrosis in Patient With Ulcerative Colitis NCT06516237 | IRCCS San Raffaele | N/A |
| Not Yet Recruiting | Utility of Low Intensity Pulsed Ultrasound Stimulation (LIPUS) to Modulate the Release of Mediators Capable of NCT06569888 | Istituto Clinico Humanitas | N/A |
| Not Yet Recruiting | Acupuncture for Symptom Relief in Adults with Mild to Moderate Ulcerative Colitis NCT06615765 | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | N/A |
| Completed | Rutin Therapy Role in Reducing Ulcerative Colitis Severity NCT07147842 | Benha University | N/A |
| Recruiting | Nutrition and Clinical Outcomes in IBD NCT06550310 | Barts & The London NHS Trust | — |
| Recruiting | A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis NCT06598943 | Eli Lilly and Company | Phase 2 |
| Not Yet Recruiting | TOFACITINIB vs TOFACITINIB WITH MESALAMINE IN ULCERATIVE COLITIS NCT06625450 | Post Graduate Institute of Medical Education and Research, Chandigarh | Phase 4 |
| Not Yet Recruiting | Prognostic Value of Confocal Endomicroscopy in Ulcerative Colitis: the CONF-UC Study NCT06624579 | FEDERICA FURFARO | N/A |
| Not Yet Recruiting | Vedolizumab in Pediatric Ulcerative Colitis- Comparison With Infliximab NCT06614387 | JAROSLAW KIERKUS | Phase 3 |
| Enrolling By Invitation | The Efficacy of Hyperbaric Oxygen-assisted Treatment for ASUC and Refractory IBD NCT07257588 | Xijing Hospital of Digestive Diseases | N/A |
| Completed | A Phase 1b Trial to Evaluate the Safety of MB310 in Patients With Active, Mild-to-Moderate Ulcerative Colitis NCT06582264 | Microbiotica Ltd | Phase 1 |
| Recruiting | Study to Assess Treatment Patterns and Outcomes With Upadacitinib in Adult Participants With Inflammatory Bowe NCT06581042 | AbbVie | — |
| Completed | Digital Support for Mental Health Intervention in Patients With Inflammatory Bowel Disease NCT06575660 | University of Chicago | N/A |
| Terminated | Study to Investigate Comparative Efficacy, Safety and Immunogenicity Between AVT16 and Entyvio NCT06570772 | Alvotech Swiss AG | Phase 3 |
| Recruiting | The Efficacy and Safety of Combining Probiotic VSL#3 With Vedolizumab for the Treatment of Moderate Ulcerative NCT06609447 | Second Affiliated Hospital, School of Medicine, Zhejiang University | Phase 4 |
| Recruiting | Critical State of "Remission-Recurrence" of Ulcerative Colitis NCT06694883 | Beijing Hospital of Traditional Chinese Medicine | — |
| Recruiting | A Study of Single and Multiple Ascending Doses of H021 in Healthy Participants NCT06627556 | Jiangsu Carephar Pharmaceutical Co., Ltd. | Phase 1 |
| Not Yet Recruiting | Transperineal Ultrasound for Assessing and Predicting Response in Hospitalized Patients with a Flare of Ulcera NCT06496516 | Sunshine Coast Hospital and Health Service | — |
| Not Yet Recruiting | Clinical Study to Evaluate the Possible Efficacy and Safety of Febuxostat in Patients With Ulcerative Colitis NCT06525974 | Tanta University | EARLY_Phase 1 |
| Active Not Recruiting | A Study to Evaluate the Safety of Ozanimod Exposure During Pregnancy in Women With Ulcerative Colitis and Thei NCT06126835 | Bristol-Myers Squibb | — |
| Withdrawn | Ulcerative Colitis Leukocyte TRAfficking After Treatment With Zeposia: the ULTRAZ Study NCT06188637 | Geert D'Haens | Phase 4 |
| Not Yet Recruiting | Outcomes of Transanal Tran-section and Single-stapled (TTSS) Ileal Pouch-Anal Anastomosis NCT06331637 | Istituto Clinico Humanitas | — |
| Enrolling By Invitation | Improving Outcomes and Reducing Disparities for Patients With Inflammatory Bowel Disease Through Epidemiology NCT06424769 | University of North Carolina, Chapel Hill | N/A |
| Completed | Association Between Effectiveness of Mirikizumab and UC Patients With High Neutrophilic Infiltration in Epithe NCT06626165 | Showa Inan General Hospital | Phase 4 |
| Recruiting | Robotic Inflammatory Bowel Disease Development, Learning and Efficacy Study NCT06579443 | University Hospitals Coventry and Warwickshire NHS Trust | — |
| Recruiting | Impact of Prebiotics in Ulcerative Colitis NCT06495658 | University of California, Los Angeles | N/A |
| Recruiting | Bowel Preparation for Colonoscopy Among Individuals With Crohn's and Ulcerative Colitis Disease. NCT06298461 | University of Manitoba | Phase 4 |
| Completed | Prevalence and Factors Associated With Sleep Disorders in Inflammatory Bowel Disease NCT06439641 | CHU de Reims | N/A |
| Completed | Intestinal Ultrasound for the Evaluation of Pouchitis and Other Outcomes After Ileal Pouch-Anal Anastomosis NCT06316999 | Mayo Clinic | N/A |
| Completed | Study of Oral Upadacitinib to Assess Change in Disease Activity and Adverse Events in Adult Participants With NCT06459297 | AbbVie | — |
| Recruiting | A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC) NCT06095128 | Takeda | Phase 4 |
| Not Yet Recruiting | T Lymphocyte Subsets in Ulcerative Colitis NCT06352515 | Assiut University | — |
| Withdrawn | SAVES-IBD: Safety & Efficacy of Aspirin vs. Standard of Care for VTE Prophylaxis After IBD Surgery NCT05104229 | Stefan Holubar MD MS FACS, FASCRS | Phase 3 |
| Unknown | Phase 2 Study of CU104 in Moderate-Severe Ulcerative Colitis NCT05907330 | Curacle Co., Ltd. | Phase 2 |
| Recruiting | Immunological Characteristics of Preclinical IBD NCT05698745 | Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa | — |
| Completed | Comparing TRIple Rectal Ultrasound Imaging Technology in Ulcerative Colitis NCT06717906 | Asian Institute of Gastroenterology, India | N/A |
| Recruiting | Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE) NCT06315179 | Seattle Children's Hospital | — |
| Completed | A Phase 1 Study to Evaluate the Safety of an Oral Biologic in Healthy Participants NCT06363383 | Mage Biologics | Phase 1 |
| Recruiting | Effect and Mechanism of Baitouweng Decoction for Large Intestine Damp-heat Syndrome of Ulcerative Colitis NCT06421818 | The Second Hospital of Nanjing Medical University | Phase 2 |
| Terminated | A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Participants With Moderate to NCT06137183 | Genentech, Inc. | Phase 2 |
| Completed | Janus Kinase Inhibitors for the Treatment of Acute Severe Ulcerative Colitis NCT06449820 | Central Hospital, Nancy, France | — |
| Recruiting | The Effects of Bromelain Supplement in Patients With Ulcerative Colitis NCT06351696 | National Nutrition and Food Technology Institute | N/A |
| Recruiting | Possible Efficacy and Safety of Mebendazole in Patients With Ulcerative Colitis Treated With Mesalamine NCT06335160 | Tanta University | N/A |
| Recruiting | A Post-Marketing Surveillance Study to Assess Safety of Ozanimod in Patients With Moderate to Severe Active UC NCT06073873 | Bristol-Myers Squibb | — |
| Recruiting | Subcutaneous Infliximab After A Previous Intravenous Dose Optimization NCT06113913 | Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW | Phase 4 |
| Completed | A Study to Evaluate the Efficacy and Safety of ZYIL1 Oral Capsules for the Treatment of Patients With Mild to NCT06398808 | Zydus Lifesciences Limited | Phase 2 |
| Active Not Recruiting | Role of Intestinal Ultrasound in Treat to Target Strategy in the Management of Inflammatory Bowel Disease : th NCT06534216 | Asian Institute of Gastroenterology, India | — |
| Recruiting | Micronutrient and Additive Modifications May Optimize Diet To Health NCT05743374 | Region Skane | N/A |
| Recruiting | Effect of Probiotic Administration on Patients With Inflammatory Bowel Disease NCT06392061 | Lebanese University | N/A |
| Recruiting | A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Mode NCT06254950 | Takeda | Phase 2 |
| Active Not Recruiting | Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis NCT06290934 | Gilead Sciences | Phase 2 |
| Withdrawn | Improving Patient Outcomes Through the Implementation of an IBD Biologic Care Pathway NCT06030882 | Jennifer Jones | N/A |
| Active Not Recruiting | A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lu NCT06257875 | AbbVie | Phase 2 |
| Unknown | Controlling the Mental Health for a Better Response to Treatment in Patients With Ulcerative Colitis NCT06306261 | IRCCS San Raffaele | — |
| Completed | Switching From Intravenous to Subcutaneous Infliximab in Adult Patients With Inflammatory Bowel Disease NCT06381518 | Zuyderland Medisch Centrum | N/A |
| Withdrawn | A Phase 1b Proof-of-concept Trial Exploring the Effects of FE 999322 and FE 999324 in Adults With Mild to Mode NCT06260267 | Ferring Pharmaceuticals | Phase 1 |
| Completed | Effects of Gluten Free Diet in Ulcerative Colitis NCT06249763 | University of Southern Denmark | N/A |
| Completed | Comparison Between Infliximab and Adalimumab on Patients With Ulcerative Colitis NCT06269185 | Vastra Gotaland Region | — |
| Unknown | Fluorescence Imaging of Adalimumab-680LT in Inflammatory Bowel Disease NCT06117423 | University Medical Center Groningen | Phase 1 / Phase 2 |
| Unknown | Analyzing the Factors in Ulcerative Colitis Patients' Clinical Trial Experiences NCT05737836 | Power Life Sciences Inc. | — |
| Recruiting | Nicotinamide Riboside in Ulcerative Colitis NCT05561738 | University of Pittsburgh | N/A |
| Recruiting | Multi-Strain Probiotics Supplementation With Standard Care in Mild to Moderate Ulcerative Colitis NCT06595719 | National University of Malaysia | N/A |
| Completed | Phase 1 Study to Investigate OD-07656 in Healthy Adult Participants NCT06206811 | Odyssey Therapeutics | Phase 1 |
| Recruiting | Fertility and Pregnancy After Surgery IBD Audit NCT04663971 | University of Campania Luigi Vanvitelli | — |
| Recruiting | IBD-Sleep: A Pilot Study Looking at Changes in Sleep Timing and IBD Symptoms NCT06094608 | University of Michigan | N/A |
| Recruiting | Ibd CAncer and seRious Infections in France (I-CARE 2) NCT06089590 | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | — |
| Unknown | Monitoring of Pediatric Inflammatory Bowel Diseases Using Multispectral Optoacoustic Tomography NCT06107179 | University of Erlangen-Nürnberg Medical School | — |
| Recruiting | Transcutaneous Electrical Acustimulation in the Treatment of Mild to Moderate Ulcerative Colitis NCT06231264 | Xijing Hospital | N/A |
| Recruiting | An Active Surveillance, Post-Authorization Study to Characterize the Safety of Tofacitinib in Patients With Mo NCT06469424 | Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa | — |
| Recruiting | Non-invasive Assessment of RECTUM (POUCH) by US (RECT-US) in a Cohort of IBD Patients NCT06407674 | IRCCS San Raffaele | — |
| Recruiting | Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC) NCT05987852 | Northwestern University | N/A |
| Completed | Prebiotics in Reducing Inflammation and Clinical Endpoints in Ulcerative Colitis (PRInCE-UC) NCT06050811 | Royal Berkshire NHS Foundation Trust | N/A |
| Recruiting | Efficacy and Safety of Upadacitinib in Inflammatory Bowel Disease NCT06780683 | Xiang Gao | — |
| Withdrawn | Hydroxocobalamin Approach for Reducing of Calprotectin With Butyrate for Ulcerative Colitis Remission NCT04259060 | Joshua Korzenik | Phase 2 |
| Unknown | Shared Decision Making in Paediatric Inflammatory Bowel Disease NCT05689892 | London Health Sciences Centre | N/A |
| Recruiting | Safety and Efficacy of Capsule FMT in Treatment-naïve Patients With Newly Diagnosed Chronic Inflammatory Disea NCT04924270 | Odense University Hospital | Phase 2 |
| Recruiting | Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis NCT06029972 | Gilead Sciences | Phase 2 |
| Active Not Recruiting | Efficacy/Safety of ALTB-268 in Subjects w/Moderately to Severely Active UC Refractory to Biologics NCT06109441 | AltruBio Inc. | Phase 2 |
| Active Not Recruiting | A Study of Efficacy and Safety of Rosnilimab in Subjects With Moderate to Severe Ulcerative Colitis (ROSETTA) NCT06127043 | AnaptysBio, Inc. | Phase 2 |
| Recruiting | Combination of Diet and Oral Budesonide for Ulcerative Colitis NCT05791487 | Wolfson Medical Center | N/A |
| Unknown | Prediction of Dietary Intervention Efficacy in Mild Ulcerative Colitis Patients Based on Fecal Microbiome Sign NCT05579483 | Wageningen University | N/A |
| Recruiting | Longitudinal Study on Bacterial Production of LPC and LPA in Patients With Inflammatory Bowel Disease NCT06548399 | McMaster University | — |
| Unknown | Pilot Study of a New Medical Food in the Management of Ulcerative Colitis NCT06116643 | Stanford University | Phase 1 |
| Recruiting | A Study of Mirikizumab (LY3074828) in Pediatric Participants With Moderately to Severely or Active Ulcerative NCT05784246 | Eli Lilly and Company | Phase 3 |
| Active Not Recruiting | Study to Assess Adverse Events, Change in Disease Activity, and How Oral Upadacitinib Moves Through the Body o NCT05782907 | AbbVie | Phase 3 |
| Unknown | Machine Learning Approach to Study the Interactions Between Environment and Intestinal Tissue Homeostasis in I NCT06120322 | IRCCS San Raffaele | — |
| Active Not Recruiting | A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely NCT06052059 | Merck Sharp & Dohme LLC | Phase 3 |
| Completed | A Clinical Trial to Assess the Safety of SOR102 in Healthy Participants and Patients With Ulcerative Colitis NCT06080048 | Sorriso Pharmaceuticals, Inc. | Phase 1 |
| Completed | Bowel Urgency in Inflammatory Bowel Disease NCT06069167 | Paris IBD Center | — |
| Recruiting | Understanding Ozanimod's MOA Via Mass Cytometry in Ulcerative Colitis NCT06311123 | University of California, San Diego | — |
| Unknown | Feasibility of a Multimodal Intervention Program to Optimize Treatment Outcomes in Ulcerative Colitis NCT05743153 | Radboud University Medical Center | N/A |
| Recruiting | Alpha Lipoic Acid in Ulcerative Colitis NCT06067698 | Tanta University | N/A |
| Recruiting | Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatr NCT04314375 | Bausch Health Americas, Inc. | Phase 4 |
| Recruiting | A Study of Vedolizumab SC Given to Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease in Sou NCT05428345 | Takeda | — |
| Active Not Recruiting | Energy Expenditure in Patients With Ulcerative Colitis Undergoing Surgery NCT06221995 | Evangelismos Hospital | — |
| Completed | A Study of LIV001 in Healthy Subjects and Those with Mild-to-Moderate Active Ulcerative Colitis (UC) NCT05975047 | Liveome Inc. | Phase 1 |
| Recruiting | FMT in Patients With Recurrent CDI and Ulcerative Colitis: Single Infusion Versus Sequential Approach NCT06071312 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Phase 1 / Phase 2 |
| Recruiting | A Study of Endoscopic Sleeve Gastroplasty for Obesity in Ulcerative Colitis NCT05739162 | Mayo Clinic | N/A |
| Active Not Recruiting | The Role of Gut Bacteria in the Immune Response to Vaccination in Patients With Ulcerative Colitis NCT06504784 | Sahlgrenska University Hospital | N/A |
| Completed | Parasitic Infections and Ulcerative Colitis: Combining Anti-parasitic and Immunomodulatory Treatments May Achi NCT06583863 | Benha University | N/A |
| Unknown | Combined Microbiota and Metabolic Signature in Ulcerative Colitis Predicts Anti-Inflammatory Therapy Success NCT05702879 | Insel Gruppe AG, University Hospital Bern | — |
| Completed | Health Benefits of Tart Cherry in Ulcerative Colitis NCT05486507 | University of Central Lancashire | N/A |
| Completed | Nutritional Counseling Impact on Ulcerative Colitis Patients NCT06824038 | Rahma Mohammed Medhat Ali | N/A |
| Active Not Recruiting | CP101 for the Treatment of Ulcerative Colitis NCT05852574 | Brigham and Women's Hospital | Phase 1 |
| Recruiting | Personalized B-fructan Diet in Inflammatory Bowel Disease Patients NCT05615779 | University of Manitoba | N/A |
| Unknown | Oncostatin M in Ulcerative Colitis Patients NCT05974332 | Beni-Suef University | N/A |
| Active Not Recruiting | Efficacy, Safety and Immunogenicity of the Proposed Biosimilar Vedolizumab PB016 in Comparison With Entyvio® NCT05771155 | Polpharma Biologics S.A. | Phase 3 |
| Completed | Study Evaluating the Persistence, Efficacy and Tolerability of Methotrexate in Inflammatory Bowel Disease Pati NCT05927064 | Central Hospital, Nancy, France | — |
| Recruiting | Exploratory Clinical Trial of Safety and Efficacy of Sacral Nerve Stimulation in Patients With Ulcerative Coli NCT05895981 | Xijing Hospital | N/A |
| Enrolling By Invitation | Long-term Efficacy and Safety of Fecal Microbiota Transplantation in Patients With Ulcerative Colitis NCT07154784 | Seoul National University Hospital | Phase 2 / Phase 3 |
| Unknown | Bleach and Urine Color in UC Patients Using 5ASA NCT06013696 | Meir Medical Center | N/A |
| Not Yet Recruiting | AppenDectomy Vs ANti TNF-a in Inducing Clinical and EnDoscopic Remission in Left-sided Ulcerative Colitis NCT05931458 | Federico II University | N/A |
| Not Yet Recruiting | Tofacitinib Versus Cyclosporine for Steroid Refractory Acute Severe Ulcerative Colitis NCT05112263 | Post Graduate Institute of Medical Education and Research, Chandigarh | N/A |
| Recruiting | Evaluation of Molecular Mechanisms of Non-response to Therapy in Patients With Inflammatory Bowel Disease NCT05733845 | Central Hospital, Nancy, France | N/A |
| Active Not Recruiting | Prospective Observational Study of Effectiveness and Safety of Filgotinib in Participants With Ulcerative Coli NCT05817942 | Alfasigma S.p.A. | — |
| Withdrawn | 90Second IBD for the Improvement of Self Efficacy and Quality of Life in Inflammatory Bowel Disease Patients NCT05686135 | Jennifer Jones | N/A |
| Unknown | Evaluate Established Anti-DEFA5 mAbs Diagnostic Efficacy and Safety in IBD NCT05663671 | Meharry Medical College | — |
| Unknown | Serum Lactate and Ulcerative Colitis NCT05876494 | Assiut University | — |
| Recruiting | IBD Strong Peer2Peer for Self-Management of Psychological Distress NCT05722236 | Jennifer Jones | N/A |
| Completed | Exploration of the Activity of DNA Located Outside of Cellular Nucleus to Amplify Inflammation in Inflammatory NCT05916274 | Centre Hospitalier Régional d'Orléans | N/A |
| Completed | Broccoli Sprouts for Mild Ulcerative Colitis NCT05507931 | University of Michigan | N/A |
| Unknown | A Personalized Approach to Abdominal Pain in Irritable Bowel Syndrome NCT05998577 | Maastricht University Medical Center | N/A |
| Active Not Recruiting | A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Colitis NCT05767021 | Eli Lilly and Company | Phase 3 |
| Recruiting | A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD) NCT05442567 | Takeda | Phase 3 |
| Terminated | VE202 in Patients With Mild-to-Moderate Ulcerative Colitis NCT05370885 | Vedanta Biosciences, Inc. | Phase 2 |
| Unknown | Saffron and Ulcerative Colitis NCT05117749 | Shiraz University of Medical Sciences | Phase 2 |
| Unknown | Non-Invasive Monitoring Through Bowel Ultrasound in Paediatric Inflammatory Bowel Disease Study NCT05673278 | Cardiff and Vale University Health Board | — |
| Terminated | Long-term Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerativ NCT05672199 | Amgen | Phase 2 |
| Unknown | Telemonitoring for IBD Goodness Examination in Russia NCT05994716 | Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department | N/A |
| Terminated | Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Moderate to Severe Ulcerative Colitis NCT05785715 | AbbVie | Phase 2 |
| Withdrawn | Define Predictors of Response to Ozanimod in UC Discovering Biomarkers in the Management of Ulcerative Colitis NCT05809583 | Beth Israel Deaconess Medical Center | — |
| Active Not Recruiting | A Study in Adults With Inflammatory Bowel Disease (IBD) Receiving Vedolizumab in the Patient Support Program ( NCT05626088 | Takeda | — |
| Completed | Assessment of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ATH-063 in Healthy Subjects NCT05807971 | Athos Therapeutics Inc | Phase 1 |
| Completed | Treatment of Ulcerative Colitis With Rectal Instillation of Qinghua Quyu Prescription(QHQYP) NCT05780723 | Beijing Hospital of Traditional Chinese Medicine | N/A |
| Not Yet Recruiting | Effect of Incentive Integrated E-IBD Chronic Disease Management Model on the Quality of Life in IBD Patients NCT05719766 | Second Affiliated Hospital, School of Medicine, Zhejiang University | N/A |
| Unknown | The Mind-Body IBD Study: Understanding the Mind-body Connection in IBD NCT06116331 | King's College London | — |
| Unknown | Saffron as Anti Inflammatory In Patients With Inflammatory Bowel Disease NCT05715099 | Minia University | Phase 4 |
| Completed | Study of ABBV-668 Oral Capsules to Assess Adverse Events and Change in Disease Activity in Adult Participants NCT05570006 | AbbVie | Phase 2 |
| Completed | A Comprehensive Self-Management Intervention for Individuals With Inflammatory Bowel Disease NCT05651542 | University of Washington | N/A |
| Unknown | Phase 2a Study to Evaluate IcBD-01 Enema in Active Ulcerative Colitis Patients NCT06353828 | CannaMore Biotechs | Phase 2 |
| Recruiting | R-3750 in Patients With Mild to Moderate Ulcerative Colitis NCT05666960 | Rise Therapeutics LLC | Phase 1 |
| Completed | Role of Roflumilast in Ulcerative Colitis NCT05684484 | Tanta University | Phase 4 |
| Recruiting | Transfer of FRozen Encapsulated Multidonor Stool Filtrate for Active Ulcerative COlitis NCT03843385 | Andreas Stallmach | Phase 3 |
| Unknown | A Phase 1b Study to Evaluate APL-1401 in Patients With Moderately to Severely Active Ulcerative Colitis NCT05743010 | Jiangsu Yahong Meditech Co., Ltd aka Asieris | Phase 1 |
| Completed | ChAracterizing the Remission Status in Patients With Ulcerative Colitis Treated by 5-ASA NCT05992142 | Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW | Phase 4 |
| Active Not Recruiting | ABTECT - Maintenance NCT05535946 | Abivax S.A. | Phase 3 |
| Unknown | Respiratory-gated Auricular Vagal Afferent Nerve Stimulation (RAVANS) Study in Ulcerative Colitis NCT05662059 | Cala Health, Inc. | N/A |
| Completed | The Evaluation of Injection Site Pain and Adherence in Patients Switching From a Low To High Concentration Ada NCT05913817 | Jamp Pharma Corporation | — |
| Recruiting | Evaluation of the SIMBA Capsule for Small Intestinal Dysbiosis NCT05633706 | Nimble Science Ltd. | — |
| Recruiting | A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune NCT06587828 | TScan Therapeutics, Inc. | — |
| Recruiting | Evaluate the Possible Efficacy and Safety of Empagliflozin in Patient With Ulcerative Colitis NCT05610956 | Tanta University | EARLY_Phase 1 |
| Active Not Recruiting | Gluten-free Diet in PSC and IBD NCT06026449 | Institute for Clinical and Experimental Medicine | N/A |
| Unknown | The Role of Intestinal Ultrasound in Monitoring the Response to Biological Therapy in Patients With Ulcerative NCT05606939 | Assiut University | — |
| Completed | Open Label Study to Assess Safety & Efficacy of QD for Induction of Remission in Pediatric Patients with UC NCT06777706 | Shaare Zedek Medical Center | N/A |
| Withdrawn | Safety and Efficacy Study of TLL018 in the Treatment of Ulcerative Colitis NCT05121402 | TLL Pharmaceutical, LLC | Phase 2 |
| Completed | ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2 NCT05507216 | Abivax S.A. | Phase 3 |
| Terminated | Study of ExoFlo for the Treatment of Medically Refractory Ulcerative Colitis NCT05176366 | Direct Biologics, LLC | Phase 1 |
| Completed | An Observational Study to Assess Change in Disease Activity and Adverse Events of Rinvoq in Adult Participants NCT05791526 | AbbVie | — |
| Recruiting | A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis NCT05287126 | Pfizer | Phase 2 |
| Unknown | the Efficacy and Safety of Diosmin in Patients With Ulcerative Colitis NCT05626166 | Tanta University | Phase 3 |
| Completed | SMART-IBD App Trial NCT06023667 | Children's Hospital Medical Center, Cincinnati | N/A |
| Recruiting | NAZA - Nottingham/Astra ZenecA Prospective IBD Cohort Study NCT06956703 | University of Nottingham | — |
| Withdrawn | The Role of Gut Microbiome in Predicting Comorbidities and Complications in Children With Inflammatory Bowel D NCT05652491 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Terminated | A Study to Evaluate Efficacy and Long-term Safety of Oral Ozanimod in Chinese Participants With Moderately to NCT05644665 | Bristol-Myers Squibb | Phase 3 |
| Unknown | Development of Novel Fecal Microbial Biomarkers for Inflammatory Bowel Disease NCT05598489 | Chinese University of Hong Kong | — |
| Recruiting | Fecal Microbiota Transplantation in Pediatric Ulcerative Colitis (UC) NCT05679622 | Biao Zou | N/A |
| Unknown | SAPHIR : Assessment of Predictive Factors for Persistence of Treatment After Initiation of Adalimumab With a B NCT05598684 | Fresenius Kabi, France | — |
| Terminated | Systems Biology of Gastrointestinal and Related Diseases NCT05579444 | Viome | — |
| Terminated | A Study to Learn About the Safety, Effects and Pharmacokinetics of Study Medication (PF-07054894) for the Trea NCT05549323 | Pfizer | Phase 1 |
| Recruiting | Study of Oral Upadacitinib to Assess Change in Disease Activity in Adult Participants With Ulcerative Colitis NCT05496348 | AbbVie | — |
| Completed | ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1 NCT05507203 | Abivax S.A. | Phase 3 |
| Completed | High Dose Steroid Therapy to Treat Flares in Patients With Inflammatory Bowel Disease (IBD) NCT05587673 | Stanford University | Phase 1 |
| Recruiting | Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission NCT05230173 | University of California, San Diego | N/A |
| Unknown | Early Intestinal Ultrasound in Predicting Treatment Response to Filgotinib in Ulcerative Colitis NCT05653791 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | — |
| Active Not Recruiting | Phase 2a to Evaluate PL-8177 in Subjects with Active Ulcerative Colitis (UC) NCT05466890 | Palatin Technologies, Inc | Phase 2 |
| Active Not Recruiting | A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence With IBD Therap NCT05316584 | University of Maryland, Baltimore | N/A |
| Completed | Health-related Physical Fitness in Patients with Inflammatory Bowel Disease NCT05482932 | Maastricht University Medical Center | — |
| Active Not Recruiting | An Observational Study to Assess Change in Disease Activity and Adverse Events of Upadacitinib in Adult Partic NCT05494606 | AbbVie | — |
| Completed | Changes in Faecal Calprotectin Levels and Participation-related Scores Following Three Weeks of Inpatient Reha NCT05500040 | Pensionsversicherungsanstalt | — |
| Completed | A Study in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) Receiving Vedolizumab in Real-World Pra NCT05384080 | Takeda | — |
| Unknown | Microbial and Human Determinants of the Onset of IBD Flares NCT05463900 | Viome | — |
| Recruiting | Efficacy of Probiotics in Patients With IBD NCT05652621 | The First Affiliated Hospital of Xinxiang Medical College | N/A |
| Recruiting | A Study to Evaluate Biomarkers in Moderate to Severe Ulcerative Colitis (UC) Patients Treated With Different T NCT05456893 | Central Hospital, Nancy, France | — |
| Terminated | A Study Evaluating the Effect of Filgotinib Dose De-escalation in Participants With Ulcerative Colitis (UC) in NCT05479058 | Galapagos NV | Phase 3 |
| Completed | Fasting-mimicking Diet in Treatment of Depressive Symptoms in IBD NCT05382897 | University of Alberta | N/A |
| Recruiting | The Use of Butyrate Therapy in Pediatric Ulcerative Colitis NCT05218850 | Children's Hospital Los Angeles | Phase 1 |
| Completed | Monitoring of Inflammatory Conditions NCT05458531 | University of Nottingham | — |
| Recruiting | Personalised Prediction of Disease Course in Ulcerative Colitis Using Multimodal Machine Learning - Part of th NCT05479617 | Copenhagen University Hospital, Hvidovre | — |
| Unknown | Efficacy of Energy Therapy in the Management of Chronic Pain Medical Condition in Children and Adolescents. NCT05394272 | King's College Hospital NHS Trust | N/A |
| Unknown | Remote Monitoring of IBD NCT05886322 | Maastricht University Medical Center | — |
| Recruiting | LFMT vs Placebo in New Biologic Start for Ulcerative Colitis NCT05327790 | University of Alberta | Phase 2 |
| Completed | Investigation of the Effects of Curcumin and Resveratrol Supplements Added to the Mediterranean Diet on Diseas NCT05761327 | Ardahan University | N/A |
| Unknown | Yuflyma® (Adalimumab), Patient Experience After Switching NCT05427942 | Celltrion HealthCare France | — |
| Completed | Carotegrast Methyl in Ulcerative Colitis NCT06897150 | Takayuki Yamamoto | Phase 4 |
| Unknown | Anal Manometry Examination in Patients With Ulcerative Colitis NCT05488041 | Assaf-Harofeh Medical Center | N/A |
| Completed | This Study is to Describe and Evaluate Patients in Finland Treated With Tofacitinib for the Treatment of Ulcer NCT05082428 | Pfizer | — |
| Withdrawn | The Correlation of a D-dimer Testing Protocol With Venous Thromboembolism in Surgical Colorectal Patients NCT05246943 | The University of Texas Medical Branch, Galveston | — |
| Recruiting | Genome Analysis Across Populations in Inflammatory Bowel Disease NCT06042387 | Mount Sinai Hospital, Canada | — |
| Unknown | bIosimilar of aDalimumab, an European evAluation NCT05190484 | Fresenius Kabi | — |
| Terminated | The Nori Health App NCT05474742 | UMC Utrecht | N/A |
| Unknown | Real-world Effectiveness of Tofacitinib on Ulcerative Colitis Associated Spondyloarthropathy NCT05431283 | Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) | — |
| Completed | First in Human, Single Ascending Dose Study NCT05844592 | Innovo Therapeutics, Inc. | Phase 1 |
| Recruiting | Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidat NCT04751396 | M.D. Anderson Cancer Center | — |
| Completed | IBD and Women's Health Wellness Program NCT05172557 | Mayo Clinic | N/A |
| Unknown | Sexual Dysfunction Among Inflammatory Bowel Disease Adults-Clinical Trial NCT05230875 | University Hospital, Bordeaux | — |
| Completed | Retrospective Observational Comparison Study Between Ustekinumab and Tofacitinib as Third Line Therapy in a Mu NCT05728008 | IRCCS San Raffaele | — |
| Recruiting | Effect of Tofacitinib on Coagulation and Platelet Function, and Its Role in Thromboembolic Events NCT05313620 | Fundación de Investigación Biomédica - Hospital Universitario de La Princesa | Phase 4 |
| Completed | The Application of Transcriptomics in the Treatment of Ulcerative Colitis With Ustekinumab NCT05896943 | Evangelismos Hospital | — |
| Unknown | Ulcerative Colitis Mayo Score With Artificial Intelligence NCT05336773 | Third Military Medical University | — |
| Terminated | Generate Real World Data On Tofacitinib Induction Therapy and Changes In Clinical and Patient Reported Outcome NCT05069259 | Pfizer | — |
| Terminated | Evaluation of SPH3127 in Patients With Mild-to-Moderate Ulcerative Colitis NCT05019742 | Shanghai Pharma Biotherapeutics USA Inc. | Phase 2 |
| Unknown | The Effect of MedicijnWijs on Adherence to Azathioprine Therapy in Adolescents With IBD NCT05321485 | Maxima Medical Center | N/A |
| Withdrawn | FMT for Remission of Active Ulcerative Colitis in Adults NCT04202211 | University of British Columbia | Phase 2 |
| Completed | The Effectiveness of Well-being Therapy on Mental Health and Self-efficacy of Patients With Ulcerative Colitis NCT05645666 | Islamic Azad University, Isfahan (Khorasgan) Branch | N/A |
| Unknown | Clinical Study of Targeting CD7 CAR-T Cells in the Treatment of Autoimmune Diseases NCT05239702 | Zhejiang University | EARLY_Phase 1 |
| Active Not Recruiting | Implementing a Multimodal RCT Intervention to Improve the Transition of Patients With Crohn's Disease From Ped NCT05221281 | The Hospital for Sick Children | N/A |
| Completed | Effect and Mechanism of Dopamine on Ulcerative Colitis NCT05214404 | Affiliated Hospital to Academy of Military Medical Sciences | — |
| Completed | A Safety Study of Lactobacillus Reuteri BGP-014 in Patients With Ulcerative Colitis NCT05118919 | BioGaia Pharma AB | Phase 1 / Phase 2 |
| Terminated | Inflammatory Bowel Disease(IBD), Treatment Response NCT05350644 | University of Southern Denmark | — |
| Completed | The Nordic IBD Treatment Strategy Trial NCT05180175 | Region Örebro County | Phase 4 |
| Recruiting | Prediction Model for Response to Biologics and Small Molecular Agent for UC NCT05186623 | Asan Medical Center | — |
| Unknown | Assessment of the Effectiveness of Progressive Relaxation Techniques in Individuals With Ulcerative Colitis NCT05788549 | Ege University | N/A |
| Terminated | Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitis NCT04987307 | Amgen | Phase 2 |
| Unknown | Efficacy of Mesalazine Combined With Biologics in the Treatment of Moderate to Severe Ulcerative Colitis NCT05205603 | Sixth Affiliated Hospital, Sun Yat-sen University | Phase 4 |